AnaptysBio, Inc. (FRA:AN6)

AnaptysBio Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,274	389	515	824	845	481
Market Cap Growth	171.50%	-24.44%	-37.53%	-2.40%	75.73%	22.34%
Enterprise Value	1,356	328	439	711	534	205
Last Close Price	45.60	12.30	19.40	29.20	30.80	17.35
PS Ratio	8.82	4.41	33.18	85.65	15.21	7.84
PB Ratio	-50.80	5.69	6.46	3.36	2.70	1.48
P/TBV Ratio	-	5.69	6.46	3.36	2.70	1.48
EV/Sales Ratio	9.43	3.72	28.31	73.84	9.62	3.34
Debt / Equity Ratio	-11.78	5.21	3.73	1.24	0.76	0.00
Net Debt / Equity Ratio	-3.31	-0.22	-0.71	-0.45	-0.77	-0.99
Net Debt / EBITDA Ratio	-3.47	0.14	0.40	1.02	4.91	16.87
Net Debt / FCF Ratio	-0.67	0.12	0.51	1.59	5.84	26.71
Asset Turnover	0.40	0.20	0.03	0.02	0.12	0.18
Quick Ratio	8.52	9.38	10.62	16.99	34.10	19.86
Current Ratio	8.68	9.51	10.87	17.17	34.40	20.01
Return on Equity (ROE)	-308.02%	-182.71%	-93.44%	-41.62%	-15.35%	-4.97%
Return on Assets (ROA)	-4.23%	-15.35%	-18.47%	-11.48%	-6.70%	-3.50%
Return on Capital Employed (ROCE)	-9.10%	-26.20%	-37.90%	-19.70%	-9.10%	-6.00%
Earnings Yield	-5.66%	-36.05%	-28.74%	-14.61%	-6.02%	-3.39%
FCF Yield	-9.73%	-33.68%	-21.36%	-8.39%	-4.92%	-2.50%
Buyback Yield / Dilution	-7.36%	-5.42%	4.41%	-2.68%	-0.47%	-0.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.